Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 245

1.

Structure and Function of HLA-A*02-Restricted Hantaan Virus Cytotoxic T-Cell Epitope That Mediates Effective Protective Responses in HLA-A2.1/K(b) Transgenic Mice.

Ma Y, Cheng L, Yuan B, Zhang Y, Zhang C, Zhang Y, Tang K, Zhuang R, Chen L, Yang K, Zhang F, Jin B.

Front Immunol. 2016 Aug 8;7:298. doi: 10.3389/fimmu.2016.00298. eCollection 2016.

2.

Meeting report: Tenth International Conference on Hantaviruses.

Papa A, Vaheri A, LeDuc JW, Krüger DH, Avšič-Županc T, Arikawa J, Song JW, Markotić A, Clement J, Liang M, Li D, Yashina LN, Jonsson CB, Schmaljohn CS.

Antiviral Res. 2016 Sep;133:234-41. doi: 10.1016/j.antiviral.2016.08.015. Epub 2016 Aug 17. Review.

PMID:
27544703
3.

Type inactivated bivalent hantavirus vaccines using dual fluorescence quantitative real-time PCR: Establishment and evaluation.

Jiang W, Ma N, Hui Q, Chen B, Qiu Y, Sun H, Li Y.

J Med Virol. 2016 Jun 15. doi: 10.1002/jmv.24599. [Epub ahead of print]

PMID:
27301695
4.

Hantavirus seropositivity in rodents in relation to habitat heterogeneity in human-shaped landscapes of Southeast Asia.

Blasdell K, Morand S, Henttonen H, Tran A, Buchy P.

Spat Spatiotemporal Epidemiol. 2016 May;17:27-35. doi: 10.1016/j.sste.2016.04.002. Epub 2016 Apr 22.

PMID:
27246270
5.

Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters.

Hammerbeck CD, Brocato RL, Bell TM, Schellhase CW, Mraz SR, Queen LA, Hooper JW.

J Virol. 2016 Jun 24;90(14):6200-15. doi: 10.1128/JVI.00304-16. Print 2016 Jul 15.

6.

Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults.

Song JY, Woo HJ, Cheong HJ, Noh JY, Baek LJ, Kim WJ.

Vaccine. 2016 Mar 4;34(10):1289-95. doi: 10.1016/j.vaccine.2016.01.031. Epub 2016 Jan 28.

PMID:
26826547
7.

Changes of HFRS Incidence Caused by Vaccine Intervention in Yichun City, China, 2005-2013.

Liu X, Zhang T, Xie C, Xie Y.

Med Sci Monit. 2016 Jan 28;22:295-301.

8.

Considerations about a Chinese vaccine preventing a national form of epidemic acute kidney injury (AKI).

Clement J.

Infect Dis (Lond). 2015 Dec 11:1-3. [Epub ahead of print] No abstract available.

PMID:
26653991
9.

History of incomplete vaccination may associate with occurrence of hemorrhagic fever with renal syndrome with relieved clinical symptoms.

Chen Y, Yang X, Ye F, Chen T, Liu Z, Zhao Y.

J Med Virol. 2016 Jul;88(7):1168-72. doi: 10.1002/jmv.24443. Epub 2015 Dec 16.

PMID:
26636561
10.

Expression and purification of the surface proteins from Andes Virus.

Beltrán-Ortiz CE, Starck-Mendez MF, Fernández Y, Farnós O, González EE, Rivas CI, Camacho F, Zuñiga FA, Toledo JR, Sánchez O.

Protein Expr Purif. 2015 Sep 12. pii: S1046-5928(15)30063-2. doi: 10.1016/j.pep.2015.09.013. [Epub ahead of print]

PMID:
26374989
11.

Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion.

Kleinfelter LM, Jangra RK, Jae LT, Herbert AS, Mittler E, Stiles KM, Wirchnianski AS, Kielian M, Brummelkamp TR, Dye JM, Chandran K.

MBio. 2015 Jun 30;6(4):e00801. doi: 10.1128/mBio.00801-15.

12.

Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.

Haese N, Brocato RL, Henderson T, Nilles ML, Kwilas SA, Josleyn MD, Hammerbeck CD, Schiltz J, Royals M, Ballantyne J, Hooper JW, Bradley DS.

PLoS Negl Trop Dis. 2015 Jun 5;9(6):e0003803. doi: 10.1371/journal.pntd.0003803. eCollection 2015.

13.

Construction and evaluation of DNA vaccine encoding Hantavirus glycoprotein N-terminal fused with lysosome-associated membrane protein.

Jiang DB, Sun YJ, Cheng LF, Zhang GF, Dong C, Jin BQ, Song CJ, Ma Y, Zhang FL, Yang K.

Vaccine. 2015 Jun 26;33(29):3367-76. doi: 10.1016/j.vaccine.2015.05.007. Epub 2015 May 28.

PMID:
26027907
14.

Kinetics and Immunodominance of Virus-Specific T Cell Responses During Hantaan Virus Infection.

Wang M, Wang J, Kang Z, Zhao Q, Wang X, Hui L.

Viral Immunol. 2015 Jun;28(5):265-71. doi: 10.1089/vim.2014.0135. Epub 2015 May 6.

PMID:
25945718
15.

A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.

McCoy JR, Mendoza JM, Spik KW, Badger C, Gomez AF, Schmaljohn CS, Sardesai NY, Broderick KE.

Hum Vaccin Immunother. 2015;11(3):746-54. doi: 10.4161/21645515.2014.978223.

16.

Animal models for some important RNA viruses of public health concern in SEARO countries: viral hemorrhagic fever.

Badole SL, Yadav PD, Patil DR, Mourya DT.

J Vector Borne Dis. 2015 Mar;52(1):1-10. Review.

17.

Gene electrotransfer clinical trials.

Heller R, Heller LC.

Adv Genet. 2015;89:235-62. doi: 10.1016/bs.adgen.2014.10.006. Epub 2014 Dec 4.

PMID:
25620013
18.

A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.

McCoy JR, Mendoza JM, Spik KW, Badger C, Gomez AF, Schmaljohn CS, Sardesai NY, Broderick KE.

Hum Vaccin Immunother. 2014;10(10):3039-47. doi: 10.4161/hv.29671. Epub 2014 Nov 21.

PMID:
25483486
19.

DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome.

Hooper JW, Brocato RL, Kwilas SA, Hammerbeck CD, Josleyn MD, Royals M, Ballantyne J, Wu H, Jiao JA, Matsushita H, Sullivan EJ.

Sci Transl Med. 2014 Nov 26;6(264):264ra162. doi: 10.1126/scitranslmed.3010082.

20.

Ribosomal protein S19-binding domain provides insights into hantavirus nucleocapsid protein-mediated translation initiation mechanism.

Ganaie SS, Haque A, Cheng E, Bonny TS, Salim NN, Mir MA.

Biochem J. 2014 Nov 15;464(1):109-21. doi: 10.1042/BJ20140449.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk